Why is Pharmaids Pharma falling/rising?

As of 21-Jul, Pharmaids Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 69.35, reflecting a rise of Rs 1.24 or 1.82%. The stock has shown strong performance recently, outperforming its sector by 2.14% today and gaining 5.08% over the last two days. It has also generated a notable return of 39.87% over the past year, significantly higher than the market's return of 1.63%. However, the company faces challenges, including operating losses and a weak long-term fundamental strength, with a negative EBITDA and a declining ability to service its debt, which may impact investor sentiment despite the recent price rise.
In the broader market context, Pharmaids Pharmaceuticals has outperformed the benchmark Sensex in the short term, with a 12.14% increase over the past week compared to a slight decline of 0.06% for the index. While the stock has shown impressive returns over longer periods, its year-to-date performance is down by 1.60%, contrasting with the Sensex's gain of 5.20%. This divergence highlights the stock's volatility and the potential risks associated with its financial health, which may temper enthusiasm among investors despite its recent gains.